Human disease characterization: real-time quantitative PCR analysis of gene expression

Citation
Jv. Snider et al., Human disease characterization: real-time quantitative PCR analysis of gene expression, DRUG DISC T, 6(20), 2001, pp. 1062-1067
Citations number
22
Categorie Soggetti
Pharmacology & Toxicology
Journal title
DRUG DISCOVERY TODAY
ISSN journal
13596446 → ACNP
Volume
6
Issue
20
Year of publication
2001
Pages
1062 - 1067
Database
ISI
SICI code
1359-6446(20011015)6:20<1062:HDCRQP>2.0.ZU;2-T
Abstract
Real-time quantitative PCR is the measurement of a fluorescent signal gener ated and measured during PCR as a consequence of amplicon synthesis. When u sed as reverse transcriptase-PCR (RT-PCR), real-time quantitative PCR has p roved to be useful in accurately measuring expression levels of specific ge ne transcripts. When applied to questions of minimal residual disease, the technique has evolved from generically detecting the presence of disease ce lls in individuals, such as the AML1-ETO fusion transcript, to the identifi cation of a specific gene, such as BCL-6, which is prognostic for determini ng the therapeutic outcome of patients with diffuse large B-cell lymphoma.